{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:21:06Z","timestamp":1790803266115,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1124\/jpet.113.205542","type":"journal-article","created":{"date-parts":[[2013,5,15]],"date-time":"2013-05-15T04:34:58Z","timestamp":1368592498000},"page":"105-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Antipruritic Effect of the Topical Phosphodiesterase 4 Inhibitor E6005 Ameliorates Skin Lesions in a Mouse Atopic Dermatitis Model"],"prefix":"10.1016","volume":"346","author":[{"given":"Naoto","family":"Ishii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Shirato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Wakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Takase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutomi","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiharu","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ieharu","family":"Hishinuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.113.205542_bib1","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.4049\/jimmunol.173.8.4847","article-title":"TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling","volume":"173","author":"Abrahamsen","year":"2004","journal-title":"J Immunol"},{"key":"10.1124\/jpet.113.205542_bib2","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1038\/sj.jid.5700810","article-title":"Thromboxane A2 induces itch-associated responses through TP receptors in the skin in mice","volume":"127","author":"Andoh","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1124\/jpet.113.205542_bib3","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1038\/jid.2009.155","article-title":"Leukotriene B(4) mediates sphingosylphosphorylcholine-induced itch-associated responses in mouse skin","volume":"129","author":"Andoh","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1124\/jpet.113.205542_bib4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1046\/j.0022-202x.2001.01484.x","article-title":"Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis","volume":"117","author":"Chan","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1124\/jpet.113.205542_bib5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/icb.2009.107","article-title":"VCAM-1 blockade delays disease onset, reduces disease severity and inflammatory cells in an atopic dermatitis model","volume":"88","author":"Chen","year":"2010","journal-title":"Immunol Cell Biol"},{"key":"10.1124\/jpet.113.205542_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1523-1747.1998.00114.x","article-title":"Cyclic nucleotide phosphodiesterase 4 subtypes are differentially expressed by primary keratinocytes and human epidermoid cell lines","volume":"110","author":"Chujor","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1124\/jpet.113.205542_bib7","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1185\/030079908X280419","article-title":"Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas","volume":"24","author":"Draelos","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1124\/jpet.113.205542_bib8","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1248\/bpb.27.1376","article-title":"Establishment of allergic dermatitis in NC\/Nga mice as a model for severe atopic dermatitis","volume":"27","author":"Gao","year":"2004","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/jpet.113.205542_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0167-5699(98)01285-7","article-title":"A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis","volume":"19","author":"Grewe","year":"1998","journal-title":"Immunol Today"},{"key":"10.1124\/jpet.113.205542_bib10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0091-6749(82)90008-2","article-title":"Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP-agonist hyporesponsiveness","volume":"70","author":"Grewe","year":"1982","journal-title":"J Allergy Clin Immunol"},{"key":"10.1124\/jpet.113.205542_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/1523-1747.ep12297888","article-title":"Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis","volume":"107","author":"Hanifin","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1124\/jpet.113.205542_bib12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.lfs.2004.07.022","article-title":"Scratching of their skin by NC\/Nga mice leads to development of dermatitis","volume":"76","author":"Hashimoto","year":"2004","journal-title":"Life Sci"},{"issue":"S14","key":"10.1124\/jpet.113.205542_bib13","first-page":"82","article-title":"Interleukin-13 and interferon-gamma producing skin resident CD8+ T cells: a vicious circle of barrier disruption of the skin in atopic dermatitis","volume":"128","author":"Hijnen","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1124\/jpet.113.205542_bib14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jaci.2006.03.047","article-title":"Cytokines and chemokines orchestrate atopic skin inflammation","volume":"118","author":"Homey","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1124\/jpet.113.205542_bib15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0014-2999(02)01933-7","article-title":"Involvement of unique mechanisms in the induction of scratching behavior in BALB\/c mice by compound 48\/80","volume":"448","author":"Inagaki","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.113.205542_bib16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0022-3565(24)29287-9","article-title":"Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation","volume":"299","author":"Jimenez","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.205542_bib17","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.4049\/jimmunol.175.3.1523","article-title":"Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages","volume":"175","author":"Jin","year":"2005","journal-title":"J Immunol"},{"key":"10.1124\/jpet.113.205542_bib18","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI21060","article-title":"New insights into atopic dermatitis","volume":"113","author":"Leung","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.113.205542_bib19","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/sj.bjp.0702911","article-title":"Suppression of human inflammatory cell function by subtype-selective PDE4 inhibitors correlates with inhibition of PDE4A and PDE4B","volume":"128","author":"Manning","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.113.205542_bib20","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/intimm\/dxl007","article-title":"IL-1beta, but not IL-1alpha, is required for antigen-specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity responses","volume":"18","author":"Nambu","year":"2006","journal-title":"Int Immunol"},{"key":"10.1124\/jpet.113.205542_bib21","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1067\/mai.2003.1595","article-title":"Allergic and nonallergic forms of atopic diseases","volume":"112","author":"Novak","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1124\/jpet.113.205542_bib22","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1517\/13543770903313753","article-title":"PDE4 inhibitors: a review of current developments (2005 - 2009)","volume":"19","author":"Pag\u00e8s","year":"2009","journal-title":"Expert Opin Ther Pat"},{"key":"10.1124\/jpet.113.205542_bib23","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1183\/09031936.94.07020306","article-title":"Rolipram, but not siguazodan or zaprinast, inhibits the excitatory noncholinergic neurotransmission in guinea-pig bronchi","volume":"7","author":"Qian","year":"1994","journal-title":"Eur Respir J"},{"key":"10.1124\/jpet.113.205542_bib24","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0028-3908(00)00142-8","article-title":"PDE4 inhibitors induce emesis in ferrets via a noradrenergic pathway","volume":"40","author":"Robichaud","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.113.205542_bib25","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1172\/JCI0215506","article-title":"Deletion of phosphodiesterase 4D in mice shortens \u03b1(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis","volume":"110","author":"Robichaud","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.113.205542_bib26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0028-3908(98)00190-7","article-title":"Emesis induced by inhibitors of type IV cyclic nucleotide phosphodiesterase (PDE IV) in the ferret","volume":"38","author":"Robichaud","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.113.205542_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2133.1995.tb08619.x","article-title":"Elevated cyclic adenosine monophosphate phosphodiesterase activity in peripheral blood mononuclear leucocytes from children with atopic dermatitis","volume":"132","author":"Sawai","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1124\/jpet.113.205542_bib28","doi-asserted-by":"crossref","first-page":"S421","DOI":"10.1016\/S0091-6749(99)70157-0","article-title":"Role of cyclic 3\u2032,5\u2032-adenosine monophosphate in the regulation of chemical mediator release and cytokine production from cultured human mast cells","volume":"103","author":"Shichijo","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1124\/jpet.113.205542_bib29","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.4049\/jimmunol.170.8.4325","article-title":"L-selectin or ICAM-1 deficiency reduces an immediate-type hypersensitivity response by preventing mast cell recruitment in repeated elicitation of contact hypersensitivity","volume":"170","author":"Shimada","year":"2003","journal-title":"J Immunol"},{"key":"10.1124\/jpet.113.205542_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejphar.2004.05.038","article-title":"Evaluation of antipruritic effects of several agents on scratching behavior by NC\/Nga mice","volume":"495","author":"Takano","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.113.205542_bib31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.0022-202X.2004.23516.x","article-title":"Repeated topical challenge with chemical antigen elicits sustained dermatitis in NC\/Nga mice in specific-pathogen-free condition","volume":"124","author":"Tomimori","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1124\/jpet.113.205542_bib35","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0022-3565(25)10457-6","article-title":"Stimulation of beta adrenoceptors in a human monocyte cell line (U937) up-regulates cyclic AMP-specific phosphodiesterase activity","volume":"263","author":"Torphy","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.205542_bib32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1164\/ajrccm.157.2.9708012","article-title":"Phosphodiesterase isozymes: molecular targets for novel antiasthma agents","volume":"157","author":"Torphy","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.113.205542_bib33","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1346-8138.1999.tb02090.x","article-title":"Itch and atopic dermatitis: an overview","volume":"26","author":"Wahlgren","year":"1999","journal-title":"J Dermatol"},{"key":"10.1124\/jpet.113.205542_bib34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1523-1747.1998.00239.x","article-title":"Intralesional cytokines in chronic oxazolone-induced contact sensitivity suggest roles for tumor necrosis factor alpha and interleukin-4","volume":"111","author":"Webb","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1124\/jpet.113.205542_bib36","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0006-2952(86)90247-9","article-title":"Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets","volume":"35","author":"Weishaar","year":"1986","journal-title":"Biochem Pharmacol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524186399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524186399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.113.205542","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:22:48Z","timestamp":1739985768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524186399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0022356524186399"],"URL":"https:\/\/doi.org\/10.1124\/jpet.113.205542","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antipruritic Effect of the Topical Phosphodiesterase 4 Inhibitor E6005 Ameliorates Skin Lesions in a Mouse Atopic Dermatitis Model","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.113.205542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}